patritumab
daiichi sankyo
['bcsm', 'patritumab', 'breast']
dr krop present novel her3 patritumab deruxtecan with exciting clinical benefit rate across all breast cancer subtypes. the future looks bright. #bcsm #asco22 
Director Breast Oncology, Lifespan Cancer Institute, Legorreta Cancer Center Brown Univ | Medical Advisor @drloveresearch | #bcsm #clinicaltrials | Views Mine